Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.25% | 1.80% | -9.60% | 12.24% | 0.08% |
| Total Depreciation and Amortization | 1.24% | 0.42% | 0.00% | 0.84% | 1.71% |
| Total Amortization of Deferred Charges | -- | -200.00% | 5.88% | -- | -- |
| Total Other Non-Cash Items | -0.41% | -2.31% | -21.84% | 4.95% | -5.31% |
| Change in Net Operating Assets | -130.82% | 218.36% | -50.69% | -529.73% | -92.28% |
| Cash from Operations | -12.69% | 46.16% | -25.99% | -3.62% | -101.50% |
| Capital Expenditure | -- | -- | -- | 100.00% | 92.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 428.32% | -246.90% | -32.43% | 169.09% | -82.81% |
| Cash from Investing | 428.32% | -246.90% | -32.43% | 173.06% | -82.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | 16,918.52% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.73% | 17,237.74% | 5,400.00% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.29% | 184.63% | -129.38% | 51.44% | -183.32% |